University Of Washington

Low income, Medicaid insurance and lack of family support were among the factors associated with transgender and nonbinary youths experiencing delays in receiving puberty blockers or gender-affirming hormones, according to study data.

The strongest risk factors for 30-day hospital readmission in patients with systemic lupus erythematosus are younger age, public insurance use and SLE-related manifestations, according to data in Arthritis Care and Research.

Real-world patients with psoriatic arthritis who receive secukinumab for 6 months maintain consistent proportions of minimal disease activity and demonstrate improved patient-reported outcomes, according to data.

University of Washington researchers are conducting a survey among kidney care professionals on how they present palliative care options to patients who are facing kidney failure.

NEW ORLEANS — Providers should take a shared decision-making approach when creating a nutrition plan for people with diabetes, according to a speaker at the American Diabetes Association Scientific Sessions.

Fewer than one in 10 adults with type 2 diabetes in the U.S. use SGLT2 inhibitors or GLP-1 receptor agonists, and only SGLT2 inhibitors have seen an increase in use over the last decade, according to study findings.

SAN FRANCISCO — A self-reported fall screening instrument may be beneficial for predicting hospitalizations among older adults with COPD, according to new findings presented at the American Thoracic Society International Conference.

SAN FRANCISCO — A session at the American Thoracic Society International Conference highlighted a new clinical practice guideline addressing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.

CHICAGO — In this video, Chris Knight, MD, FACP, and Adelaide McClintock, MD, both of the division of general internal medicine at the University of Washington, discuss highlights from their talk at the ACP’s Internal Medicine Meeting on updates in ambulatory care.

The U.S. Preventive Services Task Force has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation.